Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension (financially supported by Actelion) followed by Symposium: Drug-induced pulmonary arterial hypertension
Symposium Chairs: M. Humbert (Le Kremlin-Bicêtre, France), A. Peacock (Glasgow, United Kingdom)
Aims: The audience will be updated on important new additions to the list of PAH-inducing drugs. The aims of this symposium are to provide: awareness of the risk of drug-induced pulmonary arterial hypertension, in particular with the use of serotinergic and oncolytic drugs; and understanding concepts of vascular injury and quasi-malignant vascular remodelling in PAH.